Azitra Inc.: Clinical Trials

4 trials sponsored by Azitra Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 withdrawn. 3 Phase 1, 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Recruiting 1, Withdrawn 1
Phase 22Recruiting 1, Withdrawn 1
Not applicable1Completed 1

Follow Azitra Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
ATR04-484, Vehicle - EGFR Inhibitor-associated Rash
Phase 1 / Phase 2RecruitingAzitra Inc.322025-08-252026-10-13
Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome
ATR12-351 - Netherton Syndrome
Phase 1CompletedAzitra Inc.62024-06-162026-07-29
Study to Evaluate the Safety of ATR-04
ATR-04, Placebo - Epidermal Growth Factor, Papulopustular Rosacea
Phase 1 / Phase 2WithdrawnAzitra Inc.2024-01-012025-10-03
Safety Study of AZT-04 for Cosmetic Use
AZT-04 - Study of Three Doses of AZT-04 for Skin Appearance
Not applicableCompletedAzitra Inc.212019-01-172020-07-09

Conditions studied

Ichthyosis (1)  ·  Netherton Syndrome (1)  ·  Rosacea (1)  ·  Skin Diseases (1)

Countries

United States (3)

Top investigators

Mary Spellman, MD (1)